ECM
MYOK

ExodusPoint Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

ExodusPoint Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,835
Closed -$371K – 2429
2020
Q2 		$371K Buy
+3,835
New +$320K 0.01% 1213

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

ExodusPoint Capital Management's MYOK Position: Q3 2020 in Review

ExodusPoint Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 3,835 shares — an estimated $371K sold.

ExodusPoint Capital Management first reported a position in MYOK in Q2 2020 and held it in 1 quarter. The position peaked at $371K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • ExodusPoint Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 3,835 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $371K.
  • ExodusPoint Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • ExodusPoint Capital Management's MyoKardia, Inc. Common Stock position peaked at $371K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.